About Yokogawa’s life science portfolio
Yokogawa’s life science business started in 1996 with the development of innovative instruments based on proprietary confocal microscopy technologies, and is dedicated to providing novel products employing microscopy and/or image analysis technology for the advancement of cell biology research and drug discovery. The company’s portfolio includes the Confocal Spinning Disk Unit (CSU), CellVoyager™ High Content Analysis Systems and Software, and the new Single Cellome™ portfolio for nano-point delivery and subcellular sampling. For more information, visit https://www.yokogawa.com/eu/solutions/products-platforms/life-science/#Overview
About Yokogawa
Yokogawa provides advanced solutions in the areas of measurement, control, and information to customers across a broad range of industries, including energy, chemicals, materials, pharmaceuticals, and food. Yokogawa addresses customer issues regarding the optimization of production, assets, and the supply chain with the effective application of digital technologies, enabling the transition to autonomous operations. Founded in Tokyo in 1915, Yokogawa continues to work toward a sustainable society through its 17,000+ employees in a global network of 122 companies spanning 61 countries.
